CLDN7, claudin 7, 1366

N. diseases: 192; N. variants: 5
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0178874
Disease: Tumor Progression
Tumor Progression
0.080 Biomarker phenotype BEFREE However, conflicting results have been reported in relation to the degree of claudin-1 expression and the prognosis, suggesting that the expression level of claudin-1 alone is not sufficient to analyze the relationship between claudin-1 and cancer progression. 31769164 2020
CUI: C0178874
Disease: Tumor Progression
Tumor Progression
0.080 Biomarker phenotype BEFREE This study demonstrated that DOCK1 mediates growth and motility through down-regulated claudin-1 expression via the RRP1BDNMTclaudin-1 pathway and that claudin-1 serves as an important effector in DOCK1-mediated cancer progression and metastasis in claudin-low breast cancer cells. 31717460 2019
CUI: C0178874
Disease: Tumor Progression
Tumor Progression
0.080 Biomarker phenotype BEFREE CLDN7 may serve as a functional tumor suppressor in tumor progression and a potential biomarker and target in patients with ccRCC. 30428910 2018
CUI: C0178874
Disease: Tumor Progression
Tumor Progression
0.080 GeneticVariation phenotype BEFREE Claudins (CLDNs), the major integral membrane proteins at tight junction, play critical roles in apical cell-to-cell adhesion, maintenance of epithelial polarity, and formation of impermeable barriers between epithelial cells.We investigated in this study the expression of CLDNs- Claudin1 (CLDN1) and Claudin7 (CLDN7), and their relation to tumor progression in nasopharyngeal cancer (NPC). 28055967 2017
CUI: C0178874
Disease: Tumor Progression
Tumor Progression
0.080 AlteredExpression phenotype BEFREE Altered expression of claudin-1, claudin-7, and tricellulin in early tonsillar squamous cell carcinoma (SCC) independent of human papilloma virus (HPV) infection may lead to tumor progression. 21480761 2011
CUI: C0178874
Disease: Tumor Progression
Tumor Progression
0.080 Biomarker phenotype BEFREE Claudin-7 regulates EpCAM-mediated functions in tumor progression. 19276185 2009
CUI: C0178874
Disease: Tumor Progression
Tumor Progression
0.080 Biomarker phenotype BEFREE The data suggest that transcriptional events mediated by LPA in the tumor microenvironment influence tumor progression through modulation of cell adhesion molecules like claudin-1 and, for the first time, report an LPA-mediated expression signature in ovarian cancer that predicts a worse prognosis. 19440550 2009
CUI: C0178874
Disease: Tumor Progression
Tumor Progression
0.080 AlteredExpression phenotype BEFREE These results suggest that Cldn7 expression is an early event in gastric tumorigenesis that is maintained throughout tumor progression. 16049341 2005